259 related articles for article (PubMed ID: 23690414)
41. Association between Daytime Activity, Fatigue, Sleep, Anxiety, Depression, and Symptom Burden in Advanced Cancer Patients: A Preliminary Report.
Yennurajalingam S; Tayjasanant S; Balachandran D; Padhye NS; Williams JL; Liu DD; Frisbee-Hume S; Bruera E
J Palliat Med; 2016 Aug; 19(8):849-56. PubMed ID: 27148765
[TBL] [Abstract][Full Text] [Related]
42. Methylphenidate for fatigue in advanced cancer: a prospective open-label pilot study.
Sarhill N; Walsh D; Nelson KA; Homsi J; LeGrand S; Davis MP
Am J Hosp Palliat Care; 2001; 18(3):187-92. PubMed ID: 11406895
[TBL] [Abstract][Full Text] [Related]
43. A randomised, placebo-controlled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer.
Mar Fan HG; Clemons M; Xu W; Chemerynsky I; Breunis H; Braganza S; Tannock IF
Support Care Cancer; 2008 Jun; 16(6):577-83. PubMed ID: 17972110
[TBL] [Abstract][Full Text] [Related]
44. Effect of methylphenidate in patients with cancer-related fatigue: a systematic review and meta-analysis.
Gong S; Sheng P; Jin H; He H; Qi E; Chen W; Dong Y; Hou L
PLoS One; 2014; 9(1):e84391. PubMed ID: 24416225
[TBL] [Abstract][Full Text] [Related]
45. Parenteral hydration in patients with advanced cancer: a multicenter, double-blind, placebo-controlled randomized trial.
Bruera E; Hui D; Dalal S; Torres-Vigil I; Trumble J; Roosth J; Krauter S; Strickland C; Unger K; Palmer JL; Allo J; Frisbee-Hume S; Tarleton K
J Clin Oncol; 2013 Jan; 31(1):111-8. PubMed ID: 23169523
[TBL] [Abstract][Full Text] [Related]
46. Psychostimulants for the management of cancer-related fatigue: a systematic review and meta-analysis.
Minton O; Richardson A; Sharpe M; Hotopf M; Stone PC
J Pain Symptom Manage; 2011 Apr; 41(4):761-7. PubMed ID: 21251796
[TBL] [Abstract][Full Text] [Related]
47. Randomized, double-blind, placebo-controlled study of methylphenidate for the treatment of depression in SSRI-treated cancer patients receiving palliative care.
Sullivan DR; Mongoue-Tchokote S; Mori M; Goy E; Ganzini L
Psychooncology; 2017 Nov; 26(11):1763-1769. PubMed ID: 27429350
[TBL] [Abstract][Full Text] [Related]
48. The Use of Methylphenidate for Physical and Psychological Symptoms in Cancer Patients: A Review.
Andrew BN; Guan NC; Jaafar NRN
Curr Drug Targets; 2018; 19(8):877-887. PubMed ID: 28322161
[TBL] [Abstract][Full Text] [Related]
49. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
Newcorn JH; Nagy P; Childress AC; Frick G; Yan B; Pliszka S
CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198
[TBL] [Abstract][Full Text] [Related]
50. Anamorelin combined with physical activity, and nutritional counseling for cancer-related fatigue: a preliminary study.
Yennurajalingam S; Basen-Engquist K; Reuben JM; Fellman BM; Shete S; Maddi R; Williams JL; Dev R; Hui D; Bruera E
Support Care Cancer; 2022 Jan; 30(1):497-509. PubMed ID: 34331589
[TBL] [Abstract][Full Text] [Related]
51. Expectation effects on brain dopamine responses to methylphenidate in cocaine use disorder.
Wang GJ; Wiers CE; Shumay E; Tomasi D; Yuan K; Wong CT; Logan J; Fowler JS; Volkow ND
Transl Psychiatry; 2019 Feb; 9(1):93. PubMed ID: 30770780
[TBL] [Abstract][Full Text] [Related]
52. Clinically important improvement in the intensity of fatigue in patients with advanced cancer.
Reddy S; Bruera E; Pace E; Zhang K; Reyes-Gibby CC
J Palliat Med; 2007 Oct; 10(5):1068-75. PubMed ID: 17985963
[TBL] [Abstract][Full Text] [Related]
53. Use of methylphenidate for the management of fatigue in Chinese patients with cancer.
Siu SW; Law M; Liu RK; Wong KH; Soong IS; Kwok AO; Ng KH; Lam PT; Leung TW
Am J Hosp Palliat Care; 2014 May; 31(3):281-6. PubMed ID: 23650644
[TBL] [Abstract][Full Text] [Related]
54. Efficacy of methylphenidate for fatigue in advanced cancer patients: a preliminary study.
Sugawara Y; Akechi T; Shima Y; Okuyama T; Akizuki N; Nakano T; Uchitomi Y
Palliat Med; 2002 May; 16(3):261-3. PubMed ID: 12047006
[No Abstract] [Full Text] [Related]
55. Osmotic-release oral system methylphenidate augmentation of antidepressant monotherapy in major depressive disorder: results of a double-blind, randomized, placebo-controlled trial.
Ravindran AV; Kennedy SH; O'Donovan MC; Fallu A; Camacho F; Binder CE
J Clin Psychiatry; 2008 Jan; 69(1):87-94. PubMed ID: 18312042
[TBL] [Abstract][Full Text] [Related]
56. Comparing effects of methylphenidate, sertraline and placebo on neuropsychiatric sequelae in patients with traumatic brain injury.
Lee H; Kim SW; Kim JM; Shin IS; Yang SJ; Yoon JS
Hum Psychopharmacol; 2005 Mar; 20(2):97-104. PubMed ID: 15641125
[TBL] [Abstract][Full Text] [Related]
57. Methylphenidate for fatigue in ambulatory men with prostate cancer.
Roth AJ; Nelson C; Rosenfeld B; Scher H; Slovin S; Morris M; O'Shea N; Arauz G; Breitbart W
Cancer; 2010 Nov; 116(21):5102-10. PubMed ID: 20665492
[TBL] [Abstract][Full Text] [Related]
58. Armodafinil for sarcoidosis-associated fatigue: a double-blind, placebo-controlled, crossover trial.
Lower EE; Malhotra A; Surdulescu V; Baughman RP
J Pain Symptom Manage; 2013 Feb; 45(2):159-69. PubMed ID: 22917711
[TBL] [Abstract][Full Text] [Related]
59. Effects of Group Psychotherapy, Individual Counseling, Methylphenidate, and Placebo in the Treatment of Adult Attention-Deficit/Hyperactivity Disorder: A Randomized Clinical Trial.
Philipsen A; Jans T; Graf E; Matthies S; Borel P; Colla M; Gentschow L; Langner D; Jacob C; Groß-Lesch S; Sobanski E; Alm B; Schumacher-Stien M; Roesler M; Retz W; Retz-Junginger P; Kis B; Abdel-Hamid M; Heinrich V; Huss M; Kornmann C; Bürger A; Perlov E; Ihorst G; Schlander M; Berger M; Tebartz van Elst L;
JAMA Psychiatry; 2015 Dec; 72(12):1199-210. PubMed ID: 26536057
[TBL] [Abstract][Full Text] [Related]
60. NWP06, an extended-release oral suspension of methylphenidate, improved attention-deficit/hyperactivity disorder symptoms compared with placebo in a laboratory classroom study.
Wigal SB; Childress AC; Belden HW; Berry SA
J Child Adolesc Psychopharmacol; 2013 Feb; 23(1):3-10. PubMed ID: 23289899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
